TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35032350

Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB) with 0.4 ml/kg of plain bupivacaine 0.25%
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham ultrasound‐guided ESPB
Number of subjects: 40
Study: 33524887

Group type: EXPERIMENTAL
Intervention: Glucose ingestion prior to stress tests (CPT or TSST)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Artificial sweetener ingestion prior to stress tests (CPT or TSST)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Water ingestion prior to stress tests (CPT or TSST)
Number of subjects: 151
Study: 32000396

Group type: EXPERIMENTAL
Intervention: Xiao-Qing-Long (XQL) decoction
Number of subjects: 112

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: XQL decoction
Number of subjects: 112
Study: 36084200

Group type: EXPERIMENTAL
Intervention: iTAB + MI
Number of subjects: 255

Group type: COMPARATOR
Intervention: iTAB
Number of subjects: 255
Study: 32244933

Group type: EXPERIMENTAL
Intervention: 75 mg trans-resveratrol twice daily for 12 months
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 34808597

Group type: EXPERIMENTAL
Intervention: Vitamin C-enriched collagen (hydrolyzed collagen [HC] + C; 20 g HC + 50 mg vitamin C)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (20 g maltodextrin)
Number of subjects: 50
Study: 33491396

Group type: EXPERIMENTAL
Intervention: Air polishing with prior plaque disclosure
Number of subjects: 88

Group type: COMPARATOR
Intervention: Air polishing without plaque disclosure
Number of subjects: 88

Group type: COMPARATOR
Intervention: Rubber cup polishing without plaque disclosure
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Air polishing
Number of subjects: 88

Group type: COMPARATOR
Intervention: Rubber cup polishing
Number of subjects: 88
Study: 32151460

Group type: EXPERIMENTAL
Intervention: Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35987776

Group type: EXPERIMENTAL
Intervention: Adapted PACE
Number of subjects: 48

Group type: COMPARATOR
Intervention: PACE
Number of subjects: 48
Study: 33677425

Group type: EXPERIMENTAL
Intervention: TetraGraph (TG)
Number of subjects: 120

Group type: COMPARATOR
Intervention: TOFscan (TS)
Number of subjects: 120
Study: 33446422

Group type: EXPERIMENTAL
Intervention: Higher-dose edoxaban regimen 60/30 mg (HDER)
Number of subjects: 21105

Group type: EXPERIMENTAL
Intervention: Lower-dose edoxaban regimen 30/15 mg (LDER)
Number of subjects: 21105
Study: 33076217

Group type: EXPERIMENTAL
Intervention: Dietary intervention to reduce AGEs intake
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard of care (SOC) control arm
Number of subjects: 75
Study: 35876371

Group type: EXPERIMENTAL
Intervention: Reinforced Stapler (RS)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Standard Stapler (SS)
Number of subjects: 199
Study: 33112720

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT), 16-20 sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Attention Bias Modification (ABM), 8 sessions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Attention Bias Modification (ABM)
Number of subjects: 50
Study: 35363563

Group type: EXPERIMENTAL
Intervention: 200 mg/day caffeine
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 400 mg/day caffeine
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 34759045

Group type: EXPERIMENTAL
Intervention: Intraperitoneal local anesthesia (IPLA) with 0.2% ropivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Both groups (IPLA and control)
Number of subjects: 100
Study: 32589613

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), n=33, duration: 3 months
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control group, n=30
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT), n=33
Number of subjects: 63
Study: 35713753

Group type: COMPARATOR
Intervention: First-line chemotherapy in control arm of RCTs with immune checkpoint inhibitors (ICIs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: First-line chemotherapy in clinical practice (practice group)
Number of subjects: 0
Study: 32767058

Group type: EXPERIMENTAL
Intervention: Platinum-based chemotherapy
Number of subjects: 100
Study: 32456996

Group type: EXPERIMENTAL
Intervention: Dermis fat arthroplasty
Number of subjects: 22

Group type: COMPARATOR
Intervention: Gap arthroplasty
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 22
Study: 35948408

Group type: EXPERIMENTAL
Intervention: Intravenous ferric derisomaltose in addition to guideline‐recommended therapy for HFrEF
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care for heart failure
Number of subjects: 0
Study: 33068016

Group type: EXPERIMENTAL
Intervention: Family nursing conversations
Number of subjects: 51

Group type: COMPARATOR
Intervention: Usual home health care
Number of subjects: 51
Study: 35113479

Group type: EXPERIMENTAL
Intervention: Peer-led healthy lifestyle intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Not applicable (participants not achieving CVD risk reduction)
Number of subjects: 21
Study: 33641195

Group type: EXPERIMENTAL
Intervention: Add-on melatonin (3 mg/day) with valproate (20 mg/kg in two divided doses)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Add-on placebo
Number of subjects: 104
Study: 32791693

Group type: EXPERIMENTAL
Intervention: TEA + EA + Usual care
Number of subjects: 36

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 36
Study: 35866202

Group type: EXPERIMENTAL
Intervention: 4 essences over 4 weeks
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 8 essences over 4 weeks
Number of subjects: 80
Study: 33419704

Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy (500 pulses, 0.09 mJ/mm², twice a week for 6 weeks)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low-intensity shockwave therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 32
Study: 35613782

Group type: EXPERIMENTAL
Intervention: Bovine lactoferrin (BLF)
Number of subjects: 462

Group type: COMPARATOR
Intervention: Placebo with breast milk
Number of subjects: 462
Study: 35238917

Group type: EXPERIMENTAL
Intervention: Topical anesthetic
Number of subjects: 24

Group type: COMPARATOR
Intervention: Artificial tears (control)
Number of subjects: 24
Study: 32366249

Group type: EXPERIMENTAL
Intervention: BAT/FF 300/100
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 36207389

Group type: EXPERIMENTAL
Intervention: Neostigmine administration after tracheal intubation (Group N)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline (Group C)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neostigmine administration (Group N)
Number of subjects: 40
Study: 32811786

Group type: EXPERIMENTAL
Intervention: Graded sensory‐motor precision training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham-control
Number of subjects: 0
Study: 32212258

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) gel, n = 30
Number of subjects: 60

Group type: COMPARATOR
Intervention: Serum physiologic dressing, n = 30
Number of subjects: 60
Study: 35353941

Group type: EXPERIMENTAL
Intervention: Platelet Rich Fibrin (PRF) as a jumping gap graft material
Number of subjects: 20

Group type: COMPARATOR
Intervention: Xenograft as a jumping gap filling material
Number of subjects: 20
Study: 33775312

Group type: EXPERIMENTAL
Intervention: Metformin XR (500 mg daily increased to 1500 mg)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 26
Study: 32770353

Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin (pola)
Number of subjects: 0
Study: 32684100

Group type: EXPERIMENTAL
Intervention: Spatial exploration strategy training (one brief session of 20-30 minutes)
Number of subjects: 40
Study: 32218296

Group type: EXPERIMENTAL
Intervention: Nordic walking training with poles with an integrated resistance shock absorber (EG)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Training with classic poles (CG)
Number of subjects: 42
Study: 34933570

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 2204

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 2204
Study: 32536000

Group type: EXPERIMENTAL
Intervention: CAVI (n=14) - transfemoral implantation of an Edwards Sapien XT valve into the inferior vena cava
Number of subjects: 28

Group type: COMPARATOR
Intervention: OMT (n=14)
Number of subjects: 28
Study: 36377973

Group type: EXPERIMENTAL
Intervention: Pirtobrutinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Investigator's choice of covalent BTK inhibitor
Number of subjects: 0
Study: 33709661

Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with conventional Western medicine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional Western medicine
Number of subjects: 145

Group type: COMPARATOR
Intervention: Both groups (Electroacupuncture + Conventional vs Conventional)
Number of subjects: 145
Study: 32583501

Group type: EXPERIMENTAL
Intervention: VIPP-SD (Video-feedback Intervention to promote Positive Parenting and Sensitive Discipline)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Regular Assessment Procedure (RAP)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: VIPP-SD
Number of subjects: 56

Group type: COMPARATOR
Intervention: RAP
Number of subjects: 56
Study: 35839450

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Desmopressin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise followed by desmopressin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Desmopressin followed by exercise
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Desmopressin alone
Number of subjects: 32
Study: 34952585

Group type: EXPERIMENTAL
Intervention: Multidisciplinary biopsychosocial rehabilitation (MBR)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study: 33536119

Group type: EXPERIMENTAL
Intervention: Ligation of the inter-sphincteric fistula tract plus platelet-rich plasma
Number of subjects: 98

Group type: COMPARATOR
Intervention: Ligation of the inter-sphincteric fistula tract
Number of subjects: 98
Study: 35073519

Group type: EXPERIMENTAL
Intervention: PD-1 inhibitors
Number of subjects: 87
Study: 34195642

Group type: EXPERIMENTAL
Intervention: Module-Based Training (MBT)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Traditional Learning (TL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 30
Study: 32792033

Group type: EXPERIMENTAL
Intervention: Simulation training after a two-hour psychological first aid lecture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Two-hour psychological first aid lecture
Number of subjects: 30

Group type: COMPARATOR
Intervention: Psychological first aid handout for individual study
Number of subjects: 30
Study: 32493202

Group type: EXPERIMENTAL
Intervention: Management of liver cirrhosis complications (medical and interventional)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimized treatments for HBV and HCV
Number of subjects: 0
Study: 616285454

Group type: EXPERIMENTAL
Intervention: Patient education programme for osteoarthritis
Number of subjects: 100
Study: 35561538

Group type: EXPERIMENTAL
Intervention: 300 mg oral CBD
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 34174778

Group type: EXPERIMENTAL
Intervention: CoVideo arm
Number of subjects: 15163

Group type: COMPARATOR
Intervention: do-nothing arm
Number of subjects: 15163

Group type: COMPARATOR
Intervention: attention placebo control (APC) arm
Number of subjects: 15163
Study: 32618251

Group type: EXPERIMENTAL
Intervention: MDA (Mass Drug Administration)
Number of subjects: 300000

Group type: EXPERIMENTAL
Intervention: fMDA (Focal Mass Drug Administration)
Number of subjects: 300000

Group type: EXPERIMENTAL
Intervention: MDA
Number of subjects: 300000

Group type: EXPERIMENTAL
Intervention: fMDA
Number of subjects: 300000
Study: 616689242

Group type: EXPERIMENTAL
Intervention: Escitalopram (SSRI)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Nortryptyline (TCA)
Number of subjects: 30
Study: 34598638

Group type: EXPERIMENTAL
Intervention: Tone clouds with varying densities of tone pips
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sparse tone clouds
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tone clouds of varying densities
Number of subjects: 0
Study: 35833390

Group type: EXPERIMENTAL
Intervention: Yoga-based lifestyle modification
Number of subjects: 14135

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14135
Study: 34757312

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (1.8g per day)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study: 33092591

Group type: EXPERIMENTAL
Intervention: Umeclidinium/vilanterol 62.5/25 μg
Number of subjects: 2418

Group type: COMPARATOR
Intervention: Umeclidinium 62.5 μg
Number of subjects: 2418

Group type: COMPARATOR
Intervention: Salmeterol 50 μg
Number of subjects: 2418
Study: 35838363

Group type: EXPERIMENTAL
Intervention: rhMG53 protein (2 mg/kg, intravenous)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Normal saline control
Number of subjects: 5
Study: 33930124

Group type: EXPERIMENTAL
Intervention: Vaginal micronized progesterone 400 mg twice daily plus oral dydrogesterone 10 mg twice daily
Number of subjects: 1364

Group type: COMPARATOR
Intervention: Vaginal micronized progesterone 400 mg twice daily
Number of subjects: 1364
Study: 35470385

Group type: EXPERIMENTAL
Intervention: Consolidative stem cell transplant (SCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No consolidative stem cell transplant (SCT)
Number of subjects: 0
Study: 34469696

Group type: EXPERIMENTAL
Intervention: Glucose drink
Number of subjects: 0

Group type: COMPARATOR
Intervention: Volume-matched water (control)
Number of subjects: 0
Study: 32169111

Group type: EXPERIMENTAL
Intervention: Active stimulation plus treatment as usual (TAU)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham stimulation (placebo) plus TAU
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Active stimulation plus TAU
Number of subjects: 50
Study: 34228379

Group type: EXPERIMENTAL
Intervention: Food supplementation study arm
Number of subjects: 24837

Group type: EXPERIMENTAL
Intervention: Boys
Number of subjects: 24837

Group type: EXPERIMENTAL
Intervention: Mothers of sons
Number of subjects: 24837

Group type: COMPARATOR
Intervention: Maternal nutritional status and diet
Number of subjects: 24837
Study: 33706569

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT) for 30 minutes/day, five times/week over six weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham IMT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (IMT and Sham IMT)
Number of subjects: 50
Study: 32780949

Group type: EXPERIMENTAL
Intervention: Bupropion sustained release
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 438

Group type: EXPERIMENTAL
Intervention: Venlafaxine extended release
Number of subjects: 438

Group type: COMPARATOR
Intervention: Control group (initial SSRI)
Number of subjects: 438
Study: 35311432

Group type: EXPERIMENTAL
Intervention: Brown flaxseed (BF)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Golden flaxseed (GF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 30
Study: 34916722

Group type: COMPARATOR
Intervention: Same-day PEG-ASC regimen (5 mL sodium picosulfate in the evening and 1.5 L PEG-ASC on the day of colonoscopy)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Split-dose PEG-ASC regimen (1 L PEG-ASC before the day of colonoscopy and 1 L PEG-ASC on the day of colonoscopy)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Same-day PEG-ASC regimen
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Split-dose PEG-ASC regimen
Number of subjects: 153
Study: 35685566

Group type: EXPERIMENTAL
Intervention: Vibegron 75 mg once daily
Number of subjects: 1463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1463
Study: 32090517

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg plus IBT
Number of subjects: 282

Group type: COMPARATOR
Intervention: Placebo plus IBT
Number of subjects: 282
Study: 33947442

Group type: EXPERIMENTAL
Intervention: Continuous erector spinae plane block plus intravenous patient‐controlled analgesia with piritramide
Number of subjects: 90

Group type: COMPARATOR
Intervention: Continuous thoracic epidural analgesia with a local anesthetic‐opioid infusate
Number of subjects: 90
Study: 33619191

Group type: EXPERIMENTAL
Intervention: Microinvasive pars plana vitrectomy (PPV)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Panretinal photocoagulation (PRP)
Number of subjects: 272
Study: 32645164

Group type: EXPERIMENTAL
Intervention: Statin therapy (Pitavastatin)
Number of subjects: 7770

Group type: EXPERIMENTAL
Intervention: CKD‐EPI and Modification of Diet in Renal Disease equations
Number of subjects: 7770
Study: 35995357

Group type: EXPERIMENTAL
Intervention: Combined External Ventricular Drainage and Endoscope-Assisted Microsurgery (EAMS)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 33341937

Group type: EXPERIMENTAL
Intervention: Glyburide treatment in variant genotype group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Glyburide treatment in intermediate group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Glyburide treatment in wild-type genotype group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Glyburide dosage in variant genotype group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Glyburide dosage in wild-type genotype group
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Glyburide dosage in intermediate group
Number of subjects: 117
Study: 32893098

Group type: EXPERIMENTAL
Intervention: Neurodynamics therapy
Number of subjects: 51

Group type: COMPARATOR
Intervention: Home exercise therapy
Number of subjects: 51
Study: 35551294

Group type: EXPERIMENTAL
Intervention: Dorzagliatin
Number of subjects: 463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 463
Study: 34039457

Group type: COMPARATOR
Intervention: Universal precautions (UP) - nitrile gloves and facemask with shield
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Partial level C (PC) - rubber gloves and a passive air‐purifying respirator (APR)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Complete level C (CC) - passive APR with an anti‐chemical suit
Number of subjects: 27
Study: 33239413

Group type: EXPERIMENTAL
Intervention: Topical PHMB 0.04%
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Topical PHMB 0.06%
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Topical PHMB 0.08%
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 90
Study: 32757825

Group type: EXPERIMENTAL
Intervention: Diabetes prevention intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36177673

Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shock wave therapy (LiESWT) at 0.25 mJ/mm2 and 3 pulses/second for a total of 3000 pulses over 8 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-intensity extracorporeal shock wave therapy (LiESWT)
Number of subjects: 30
Study: 34283220

Group type: EXPERIMENTAL
Intervention: Modified uvulopalatopharyngoplasty with tonsillectomy (if tonsils present) combined with radiofrequency tongue ablation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Surgical intervention
Number of subjects: 43
Study: 32901950

Group type: EXPERIMENTAL
Intervention: 1 minute cryoballoon application (short)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: 2 minutes cryoballoon application (medium)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: 3 minutes cryoballoon application (long)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Overall (all groups)
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Left superior PV
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: Right superior PV (RSPV)
Number of subjects: 222
Study: 35074890

Group type: EXPERIMENTAL
Intervention: Dual therapy (cilostazol with aspirin or clopidogrel) in the 15-28 days group
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Dual therapy (cilostazol with aspirin or clopidogrel) in the 29-180 days group
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Monotherapy (aspirin or clopidogrel) in the 8-14 days group
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Dual therapy (cilostazol with aspirin or clopidogrel)
Number of subjects: 1879

Group type: COMPARATOR
Intervention: Monotherapy (aspirin or clopidogrel)
Number of subjects: 1879
Study: 32406808

Group type: EXPERIMENTAL
Intervention: Solid back
Number of subjects: 50

Group type: COMPARATOR
Intervention: Upholstered back
Number of subjects: 50
Study: 32862249

Group type: COMPARATOR
Intervention: Conventional anesthesia
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Computerized anesthesia (Calaject®)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Preference for anesthesia technique
Number of subjects: 40
Study: 35284929

Group type: EXPERIMENTAL
Intervention: Shield during hand CT scan (MDCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Shield during hand CT scan (CBCT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-shielded group
Number of subjects: 0
Study: 33793713

Group type: EXPERIMENTAL
Intervention: Grade A1 (single tumour 3 cm or smaller and anatomical R0 resection)
Number of subjects: 16931

Group type: EXPERIMENTAL
Intervention: Grade A2 (single tumour larger than 3 cm, or non-anatomical R0 resection)
Number of subjects: 16931

Group type: EXPERIMENTAL
Intervention: Grade B (multiple tumours, or vascular invasion, and R0 resection)
Number of subjects: 16931

Group type: EXPERIMENTAL
Intervention: Grade C (multiple tumours with vascular invasion and R0 resection, or R1 resection)
Number of subjects: 16931